Suggestions
Teri Loxam
Chief Financial Officer at SQZ Biotechnologies
Professional Background
Teri Loxam is an accomplished financial executive with a distinguished track record in investor relations and corporate communication. Currently, she holds the position of Chief Financial Officer at SQZ Biotechnologies, where she leverages her extensive experience in strategic financial management to drive growth and enhance shareholder value. Loxam has built a reputation for her keen understanding of the biotechnology industry and her ability to create compelling narratives that resonate with investors.
Prior to her role at SQZ Biotechnologies, Teri made significant contributions in various high-level positions at leading global firms. She served as the Senior Vice President of Investor Relations and Global Communications at Merck, one of the world’s leading pharmaceutical companies. In this role, she was instrumental in developing and implementing strategies that effectively communicated Merck’s financial performance and corporate strategy to its investor community.
Her career at Merck also included her prior role as Vice President of Investor Relations, where she guided the company's investor engagement and communication strategies during a pivotal period of growth and transformation. Teri also honed her skills in investor relations through her leadership at IMAX as Vice President of Investor Relations and at Bristol-Myers Squibb, where she served as Executive Director of Investor Relations and held other notable positions such as Director of Treasury Planning & Analysis and Director of Strategic Planning & Portfolio Management.
Throughout her career, Loxam has been recognized for her ability to build strong relationships with investors and stakeholders, her expertise in financial analysis, and her strategic thinking.
Education and Achievements
Teri Loxam’s academic background is rooted in strong scientific and business foundations. She earned her Bachelor of Science degree in Biology from the University of Victoria, where her interest in the life sciences began. Understanding the intersection between biology and business, she pursued an MBA from the University of California, Irvine, at The Paul Merage School of Business. This combination of education has provided her with a unique perspective that she applies in her current and previous roles in the biotech and pharmaceutical sectors.
Her educational achievements have set the stage for an impressive career that showcases her analytical skills and business acumen. Teri’s strategic insights, derived from her scientific and business education, have enabled her to lead teams effectively and drive initiatives that enhance corporate growth.
Notable Achievements
Throughout her career, Teri Loxam has achieved several noteworthy accomplishments that underscore her expertise in corporate finance and investor relations:
- Leadership in Investor Relations: Teri has been recognized as a leader in the field of investor relations, where she effectively managed communications that have positively influenced stock performance and investor perceptions for companies like Merck and IMAX.
- Strategic Financial Management: Teri played a crucial role in implementing financial strategies within Bristol-Myers Squibb, contributing to the company's long-term financial health and strategic objectives.
- Adaptability across Industries: With her diverse roles in prominent organizations, Teri has demonstrated an exceptional ability to adapt her skills across various industries, including pharmaceuticals and entertainment, showcasing her versatility and leadership.
- Thought Leadership: Teri’s insights into financial strategies and investor relations have positioned her as a thought leader in her field, contributing to discussions on effective communication strategies for engaging with investors in the biotech industry.
tags':['Chief Financial Officer','Investor Relations','Global Communications','Biotechnology Industry','Financial Management','Corporate Communication','Bristol-Myers Squibb','Merck','IMAX','University of California','University of Victoria','MBA','B.Sc Biology','Strategic Planning and Analysis','Business Leadership'],
